FI118324B - Tuggbara flubendazoltabletter för sällskapsdjur - Google Patents

Tuggbara flubendazoltabletter för sällskapsdjur Download PDF

Info

Publication number
FI118324B
FI118324B FI964623A FI964623A FI118324B FI 118324 B FI118324 B FI 118324B FI 964623 A FI964623 A FI 964623A FI 964623 A FI964623 A FI 964623A FI 118324 B FI118324 B FI 118324B
Authority
FI
Finland
Prior art keywords
composition
flubendazole
companion animals
composition according
dogs
Prior art date
Application number
FI964623A
Other languages
English (en)
Finnish (fi)
Other versions
FI964623A (sv
FI964623A0 (sv
Inventor
Paul Marie Victor Gilis
Eugeen Marie Jozef Jans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI964623A publication Critical patent/FI964623A/sv
Publication of FI964623A0 publication Critical patent/FI964623A0/sv
Application granted granted Critical
Publication of FI118324B publication Critical patent/FI118324B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Claims (10)

1. Maskmedicinkomposition som är smaklig för säll-skapsdjur, kännetecknad av att den innehäller fluben- 5 dazol och bryggerijäst.
2. Komposition enligt patentkrav 1, kännetecknad av att sällskapsdjuren är hundar.
3. Komposition enligt patentkrav 1, kännetecknad av att mängden bryggerijäst varierar mellan 40 % och 10 70 %.
4. Komposition enligt patentkrav 1, kännetecknad av att den innehäller i vikt baserat pä kompositio-nens totalvikt: flubendazol : 20 % - 40 % 15 bryggerijäst : 40 % - 70 % fyllnadsmedel : 0 % - 25 % bindningsmedel : 0 % - 4 % aromämnen : 0,001 % - 0,5 % fuktande medel : 0 % - 0,5 % 20 smörjmedel : 0,1 % - 1,5 %
5. Kompositition enligt patentkrav 4, känne- t e c k n a d av att den innehäller i vikt baserat pä kompo- ·*·.· sitionens totalvikt: • · . flubendazol : 22 % - 33 % .·, 25 bryggerijäst : 50 % - 65 % "" hydroxipropylmetyl- I" cellulosa : 2 % - 3 % · ♦ · *·* * aromämenen : 0,1 % - 0,2 %
6. Komposition enligt patentkrav 5, känne- : '*· 30 tecknad av att nämnda komposition föreligger i form av ill en tuggtablett. ί·.
7. Komposition enligt patentkrav 6, känne- *···, tecknad av att tabletten har följande sammansättning: ♦ « "* flubendazol : 220,0 mg 22,00 % ·** * 35 bryggerijäst : 500,4 mg 50,04 % ··· 5,,,! kolloidal kiseldioxid : 10,0 mg 1,00 % 118324 hypromellos 2910 15 CpS : 25,0 mg 2,50 % natriumlaurylsulfat : 3,0 mg 0,30 % kristallin sorbitol : 110,0 mg 11,00 % 5 köttarom : 1,6 mg 0,16 % magnesiumstearat : 5,0 mg 0,50 % mikrokristallin cellulosa : 125,0 mg 12,50 %
8. Förfarande för framställning av en komposition 10 enligt patentkrav 1 - 7, kännetecknat av att fluoben- dazol blandas noggrant med konstituens.
9. Användning av en komposition enligt patentkrav 1 för framställning av ett läkemedel för att behandla säll-skapsdjur som lider av masksjukdom.
10. Användning enligt patentkrav 9, känneteck nat av att sällskapsdjuren är hundar. i« * I t I • · * · • · « « « • *· • · • w m · • m # • ··· ·*·· • · · • · Φ ··· *·· ♦' · · li» ·· • · • «· ··· % * t « ··· • · • a • · · ··· • * • · ··· «·· • ♦ # • · · * ··· • · • · ···'
FI964623A 1994-05-20 1996-11-19 Tuggbara flubendazoltabletter för sällskapsdjur FI118324B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94201434 1994-05-20
EP94201434 1994-05-20
PCT/EP1995/001801 WO1995031963A1 (en) 1994-05-20 1995-05-12 Chewable flubendazole tablets for companion animals
EP9501801 1995-05-12

Publications (3)

Publication Number Publication Date
FI964623A FI964623A (sv) 1996-11-19
FI964623A0 FI964623A0 (sv) 1996-11-19
FI118324B true FI118324B (sv) 2007-10-15

Family

ID=8216895

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964623A FI118324B (sv) 1994-05-20 1996-11-19 Tuggbara flubendazoltabletter för sällskapsdjur

Country Status (23)

Country Link
US (1) US5824336A (sv)
EP (1) EP0760648B1 (sv)
JP (1) JPH10501211A (sv)
AT (1) ATE208611T1 (sv)
AU (1) AU690994B2 (sv)
BR (1) BR9507637A (sv)
CA (1) CA2190357C (sv)
CY (1) CY2255B1 (sv)
CZ (1) CZ290406B6 (sv)
DE (1) DE69523912T2 (sv)
DK (1) DK0760648T3 (sv)
ES (1) ES2167436T3 (sv)
FI (1) FI118324B (sv)
HK (1) HK1010695A1 (sv)
HU (1) HU225958B1 (sv)
IL (1) IL113782A (sv)
NO (1) NO313402B1 (sv)
NZ (1) NZ285766A (sv)
PL (1) PL185332B1 (sv)
PT (1) PT760648E (sv)
SI (1) SI0760648T1 (sv)
WO (1) WO1995031963A1 (sv)
ZA (1) ZA954128B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317560A (en) * 1996-09-20 1998-04-01 Edmund John Hilary Campion Anti-parasite medication for pets
WO2001021178A2 (en) * 1999-09-22 2001-03-29 Akzo Nobel, N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20050271708A1 (en) * 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1759692A3 (en) * 2003-03-10 2007-09-12 Novartis AG Taste-masked solid veterinary compositions
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
HUE024906T2 (en) 2003-08-26 2016-02-29 Shire Biopharmaceuticals Holdings Ireland Ltd Pharmaceutical composition containing lanthanum compounds
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
ME03323B (me) 2012-02-06 2019-10-20 Merial Inc Paraziticidne oralne veterinarske kompozicije koje sadrže sistemski djelujuća aktivna sredstva, metodi i primjene istih
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
JP6088637B2 (ja) 2012-04-04 2017-03-01 インターベット インターナショナル ベー． フェー． イソオキサゾリン化合物のための固形経口医薬組成物
WO2014141223A1 (en) 2013-03-15 2014-09-18 Argenta Manufacturing Limited Chewable formulation
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
JP6117079B2 (ja) * 2013-10-01 2017-04-19 富士フイルム株式会社 チュアブル錠用組成物及びチュアブル錠
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE944581C (de) * 1953-10-15 1956-06-21 Waldhof Zellstoff Fab Verfahren zur Herstellung einer Pilengrundmasse
US4578268A (en) * 1979-07-26 1986-03-25 American Cyanamid Company Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
AU5957480A (en) * 1979-07-26 1981-01-29 American Cyanamid Company Diethyl carbamazine resinate
JPS5821615A (ja) * 1981-07-29 1983-02-08 Fujisawa Pharmaceut Co Ltd 草食獣の肝蛭症の予防治療剤
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique

Also Published As

Publication number Publication date
PL185332B1 (pl) 2003-04-30
CA2190357C (en) 2007-04-17
FI964623A (sv) 1996-11-19
EP0760648B1 (en) 2001-11-14
FI964623A0 (sv) 1996-11-19
HUT74988A (en) 1997-03-28
HK1010695A1 (en) 1999-06-25
HU225958B1 (en) 2008-01-28
JPH10501211A (ja) 1998-02-03
NO964912L (no) 1996-11-19
CY2255B1 (en) 2003-07-04
BR9507637A (pt) 1997-10-07
US5824336A (en) 1998-10-20
AU2527295A (en) 1995-12-18
AU690994B2 (en) 1998-05-07
ZA954128B (en) 1996-11-19
DE69523912T2 (de) 2002-06-27
HU9603215D0 (en) 1997-01-28
NZ285766A (en) 1997-09-22
CZ290406B6 (cs) 2002-07-17
SI0760648T1 (en) 2002-04-30
ATE208611T1 (de) 2001-11-15
CZ333596A3 (en) 1997-02-12
PT760648E (pt) 2002-04-29
EP0760648A1 (en) 1997-03-12
DK0760648T3 (da) 2002-02-25
IL113782A0 (en) 1995-08-31
DE69523912D1 (de) 2001-12-20
PL317227A1 (en) 1997-03-17
CA2190357A1 (en) 1995-11-30
NO313402B1 (no) 2002-09-30
NO964912D0 (no) 1996-11-19
ES2167436T3 (es) 2002-05-16
IL113782A (en) 1999-08-17
WO1995031963A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
FI118324B (sv) Tuggbara flubendazoltabletter för sällskapsdjur
EP2063869B1 (en) Soft chewable veterinary antibiotic formulations
US4320116A (en) Foodstuffs, animal feeding stuffs and pharmaceutical preparations containing an antibacterial system
JP6149906B2 (ja) 動物に給餌するための生成物、および、動物に給餌するための生成物の製造工程
EP1913943B1 (en) Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria
US20030190343A1 (en) Palatable pharmaceutical compositions for companion animals
RU2001128302A (ru) Продукт для питания домашних животных для поддержания здоровья суставов и ослабления артритных симптомов у домашних животных
CN104666401B (zh) 一种兽用中西药复方口崩微粉片及其制备方法
US20080188546A1 (en) Preventive or therapeutic agents for decubitus
US7582612B2 (en) Multi-action anthelmintic formulations
CN100351232C (zh) 抗肥胖剂
KR101473851B1 (ko) 모넨신을 주성분으로 하는 가축의 콕시듐증 예방용 펠릿형 조성물 및 그의 제조방법
US20040241257A1 (en) Animal food supplement compositions and methods of use
EP2526781B1 (en) Product for feeding animals
CN110898214A (zh) 用于宠物的止泻组合物及其制备方法
KR20040046570A (ko) 양파 및 마늘을 이용한 분말청국장의 제조방법
KR102663613B1 (ko) 형개 추출물을 유효성분으로 포함하는 고양이 전염성 복막염 예방 또는 치료용 조성물
NZ537294A (en) Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
JP7167288B2 (ja) 圧縮成型製剤
CN100351231C (zh) 脂质代谢改善剂
JP2933241B2 (ja) 免疫賦活方法及び免疫賦活剤
JP2004357504A (ja) ペットのストレス軽減用剤

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118324

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: ELANCO ANIMAL HEALTH IRELAND LIMITED

Free format text: ELANCO ANIMAL HEALTH IRELAND LIMITED

MA Patent expired